157 related articles for article (PubMed ID: 36056230)
1. Does isolated nuchal translucency from 2.5 to 2.9 mm increase the risk of fetal chromosome disease?
Yin D; Chen L; Wang L; Zeng Y; Tang F; Wang J
Mol Genet Genomics; 2022 Nov; 297(6):1643-1648. PubMed ID: 36056230
[TBL] [Abstract][Full Text] [Related]
2. Application of expanded noninvasive prenatal test in prenatal diagnosis of fetuses with increased nuchal translucency.
Xie X; Zhou H; Zhao Q; Lu Y; Meng Y
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6213-6218. PubMed ID: 34649482
[TBL] [Abstract][Full Text] [Related]
3. Prenatal screening for fetal aneuploidy in singleton pregnancies.
Chitayat D; Langlois S; Douglas Wilson R; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
[TBL] [Abstract][Full Text] [Related]
4. Prenatal screening for and diagnosis of aneuploidy in twin pregnancies.
Audibert F; Gagnon A; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):754-67. PubMed ID: 21749753
[TBL] [Abstract][Full Text] [Related]
5. [Prospective cohort study of fetal nuchal translucency in first-trimester and pregnancy outcome].
Tang HR; Zhang Y; Ru T; Li J; Yang L; Xu Y; Duan HL; Wang Y; Wang Y; Hu YL; Zhang Y; Zheng MM
Zhonghua Fu Chan Ke Za Zhi; 2020 Feb; 55(2):94-99. PubMed ID: 32146737
[No Abstract] [Full Text] [Related]
6. Microarray and RASopathy-disorder testing in fetuses with increased nuchal translucency.
Sinajon P; Chitayat D; Roifman M; Wasim S; Carmona S; Ryan G; Noor A; Kolomietz E; Chong K
Ultrasound Obstet Gynecol; 2020 Mar; 55(3):383-390. PubMed ID: 31115076
[TBL] [Abstract][Full Text] [Related]
7. Should cell-free DNA testing be used in pregnancy with increased fetal nuchal translucency?
Miranda J; Paz Y Miño F; Borobio V; Badenas C; Rodriguez-Revenga L; Pauta M; Borrell A
Ultrasound Obstet Gynecol; 2020 May; 55(5):645-651. PubMed ID: 31301176
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of results of prenatal diagnosis by different techniques for fetuses with increased nuchal translucency].
Dai W; Liu X; Ma X; Yu Z; Li H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 May; 40(5):532-537. PubMed ID: 37102284
[TBL] [Abstract][Full Text] [Related]
9. Reexamining the optimal nuchal translucency cutoff for diagnostic testing in the cell-free DNA and microarray era: results from the Victorian Perinatal Record Linkage study.
Hui L; Pynaker C; Bonacquisto L; Lindquist A; Poulton A; Kluckow E; Hutchinson B; Norris F; Pertile MD; Gugasyan L; Kulkarni A; Harraway J; Howden A; McCoy R; da Silva Costa F; Menezes M; Palma-Dias R; Nisbet D; Martin N; Bethune M; Poulakis Z; Halliday J
Am J Obstet Gynecol; 2021 Nov; 225(5):527.e1-527.e12. PubMed ID: 33957116
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic yield of copy number variation sequencing in fetuses with increased nuchal translucency: a retrospective study.
Yang X; Bian X; Shi X; Ding J; Tang H; Xu P; Deng D; Zeng W; Chen S; Qiao F; Feng L; Wu Y
Arch Gynecol Obstet; 2024 Jan; 309(1):139-144. PubMed ID: 36602560
[TBL] [Abstract][Full Text] [Related]
11. [Application of chromosomal microarray analysis in prenatal diagnosis of fetuses with increased nuchal translucency].
Ni M; Li J; Zhu X; Zhu Y; Gu L; Wu X; Yang Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Oct; 36(10):970-974. PubMed ID: 31598938
[TBL] [Abstract][Full Text] [Related]
12. Clinical application of chromosomal microarray analysis in fetuses with increased nuchal translucency and normal karyotype.
Su L; Huang H; An G; Cai M; Wu X; Li Y; Xie X; Lin Y; Wang M; Xu L
Mol Genet Genomic Med; 2019 Aug; 7(8):e811. PubMed ID: 31209990
[TBL] [Abstract][Full Text] [Related]
13. A Chinese multicenter retrospective study of isolated increased nuchal translucency associated chromosome anomaly and prenatal diagnostic suggestions.
Jin H; Wang J; Zhang G; Jiao H; Zhu J; Li Z; Chen C; Zhang X; Huang H; Wang J
Sci Rep; 2021 Mar; 11(1):5596. PubMed ID: 33692422
[TBL] [Abstract][Full Text] [Related]
14. [Increased nuchal translucency and cystic hygroma in the first trimester: prenatal diagnosis and neonatal outcome].
Ducarme G; Graesslin O; Alanio E; Bige V; Gaillard D; Gabriel R
Gynecol Obstet Fertil; 2005 Oct; 33(10):750-4. PubMed ID: 16139544
[TBL] [Abstract][Full Text] [Related]
15. [Ultrasound screening for Down syndrome and other chromosomal abnormalities by fetal nuchal translucency measurement between 11-14 weeks of gestation].
Dimitrova V; Markov D; Chernev T; Karag'ozova Zh; Mazneĭkova V; Andonova S; Vŭzharova R
Akush Ginekol (Sofiia); 2005; 44(1):32-7. PubMed ID: 15853009
[TBL] [Abstract][Full Text] [Related]
16. Whole exome sequencing in fetuses with isolated increased nuchal translucency: a systematic review and meta-analysis.
Di Girolamo R; Rizzo G; Khalil A; Alameddine S; Lisi G; Liberati M; Novelli A; D'Antonio F
J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2193285. PubMed ID: 37019452
[TBL] [Abstract][Full Text] [Related]
17. Prospective chromosome analysis of 3429 amniocentesis samples in China using copy number variation sequencing.
Wang J; Chen L; Zhou C; Wang L; Xie H; Xiao Y; Zhu H; Hu T; Zhang Z; Zhu Q; Liu Z; Liu S; Wang H; Xu M; Ren Z; Yu F; Cram DS; Liu H
Am J Obstet Gynecol; 2018 Sep; 219(3):287.e1-287.e18. PubMed ID: 29852155
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and management of fetal nuchal translucency.
Jackson M; Rose NC
Semin Roentgenol; 1998 Oct; 33(4):333-8. PubMed ID: 9800243
[TBL] [Abstract][Full Text] [Related]
19. Fetal exome sequencing for isolated increased nuchal translucency: should we be doing it?
Mellis R; Eberhardt RY; Hamilton SJ; ; McMullan DJ; Kilby MD; Maher ER; Hurles ME; Giordano JL; Aggarwal V; Goldstein DB; Wapner RJ; Chitty LS
BJOG; 2022 Jan; 129(1):52-61. PubMed ID: 34411415
[TBL] [Abstract][Full Text] [Related]
20. Prenatal whole-exome sequencing in fetuses with increased nuchal translucency.
Cao C; Liu F; Yang Y; Zhang Q; Huang J; Liu X
Mol Genet Genomic Med; 2023 Nov; 11(11):e2246. PubMed ID: 37766479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
